![Extracting Safety Signals from Social Media through Artificial Intelligence](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Whether companies like it or not, consumers are discussing their products in social media forums. Comments about adverse events exist on patient forums, and on more generic social forums such as Facebook and Twitter. While much of what is said is not relevant or verifiable, there are safety signals that companies should be paying attention to, and that go to the heart of pharmacovigilance and social media.
Learn More![LifeSphere Safety: Extending a Worldwide Pharmacovigilance Program to the Japanese Market](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
An integrated safety and pharmacovigilance software system with worldwide business processes helps companies realize significant productivity benefits. This position paper…
Learn More![Pharmacovigilance and EU GDPR Compliance](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Compliance with the new General Data Protection Regulation (GDPR), scheduled to become effective 25th May 2018, applies to all organizations that control or process personal data of European Union (EU) residents with or without a physical presence in the EU.
Learn More![Lifting the Tedium of Medical Literature Monitoring with Automation](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
One of the key roles of pharmacovigilance departments is to understand the benefit-risk profile of a drug. But departments are often bogged down by manual tasks that can absorb time, which might be better spent on value-centric activities. Perhaps the most tedious pharmacovigilance activity is medical literature monitoring (MLM), and as we discussed in our last blog, manual, repetitive tasks are a primary cause of employee dissatisfaction.
Learn More![Survey Finds Slow But Steady Move toward a Unified Clinical Platform](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
During a recent webcast, ArisGlobal carried out an insightful survey, which found that visibility and reporting inefficiencies remain a headache.
Learn More![National Pharmacovigilance Systems & Role of Technology in Bridging the Disparities](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Download this white paper to learn about. Pharmacovigilance with an ‘e’ – the “4pt-classification” of the state of evolution of national pharmacovigilance systems Modern technologies in pharmacovigilance system – the way forward for national PV systems Advanced pharmacovigilance technologies –the role ‘e- enablement’ technology plays in bridging the gaps in pharmacovigilance of regulatory authorities across the world
Learn More![ArisGlobal Announces LifeSphere® Publishing and LifeSphere® Analytics to Streamline Regulatory Submissions and Reporting](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
ArisGlobal, a leading provider of integrated cloud-based software solutions for life sciences, announces LifeSphere Publishing and LifeSphere Analytics, new solutions that will integrate with LifeSphere RIMS™ and LifeSphere IDMP™ to offer the most complete, unified platform for regulatory affairs. LifeSphere Publishing delivers streamlined publishing capabilities and content management, and LifeSphere Analytics ensures all reports and analyses will comply with regulatory requirements.
Learn More![Benefits & Challenges of Artificial Intelligence in Pharmacovigilance](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Pharmacovigilance is at a crossroads. The best, most innovative way forward for PV departments may well be automation, as they address the challenges (or market pull factors) and opportunities (or technology push capabilities).
Learn More![Medical Information: Easy Integration of LifeSphere® MI with Your Chosen CRM Lets You Have Your Cake and Eat It Too](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
As a medical information software provider, it is necessary to recognize that there is some decent software out there in the life science’s space
Learn More![Re-Think Your Integrated CTMS: Why Moving to Unified Platform is the Only Path Forward](https://www.arisglobal.com/wp-content/themes/arisglobal-theme/assets/img/default-images/generic-teaser-placeholder.jpg)
Most sponsors and clinical research organisations manage clinical trials using an average of three to five independent core systems. Creating…
Learn More